Methoxyflurane CPG Flashcards
Methoxyflurane - Presentation
3 mL glass bottle
Methoxyflurane - Pharmacology
Inhalation analgesic agent at low concentrations
Methoxyflurane - Metabolism
Excreted mainly by the lungs
By the liver
Methoxyflurane - Primary emergency indications
- Pain relief
Methoxyflurane - Contraindications
- Pre-existing renal disease / renal impairment
- Concurrent use of tetracycline antibiotics
- Exceeding total dose of 6 mL in 24hr period
- Personal or family history of malignant hyperthermia
- Muscular dystrophy
Methoxyflurane - Precautions
- The Penthrox inhaler must be hand-held by the Pt so that if unconsciousness occurs it will fall from the patient’s face. Occasionally the operator may need to assist but must continuously assess the level of consciousness
- Pre-eclampsia
- Concurrent use with oxytocin may cause hypotension
Methoxyflurane - Route of administration
Self-administered under supervision using the hand held Penthrox inhaler
Methoxyflurane - Side effects
Drowsiness
Decrease in blood pressure and bradycardia (rare)
Exceeding the maximum total dose of 6 mL in a 24hr period may lead to renal toxicity
Methoxyflurane - Special notes
The maximum initial priming dose for Methoxyflurane is 3 mL. This will provide approximately 25 minutes of analgesia and may be followed by one further 3 mL dose once the initial dose is exhausted if required. Analgesia commences after 8 - 10 breaths and lasts approximately 3 - 5 minutes once discontinued.
Do not administer in a confined space. Ensure adequate ventilation in ambulance.
Malignant hyperthermia is a very rare condition that can be induced by volatile anaesthetics such as methoxyflurane. Ask Pt about any past history or family history of adverse reactions to inhaled anaesthetics.
In patients with muscular dystrophy, volatile agents may precipitate life-threatening rhabdomyolysis.